SCI-110

· Neurothera Labs Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SCI-110, covering 2022-02-14 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: SCI-110 in the Treatment of Tourette Syndrome [Phase 2]